North America Laboratory Animal Diets Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Diet Type (Standard Diets, Irradiated Diets, and Autoclavable Diets), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Disco

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,000	117 Pages	The Insight Partners	December, 2022	TIP17606829

Best Price Guarantee
Price	from $3,000
Length	117 Pages
Publisher	The Insight Partners
Published Date	December, 2022
SKU	TIP17606829

North America Laboratory Animal Diets Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Diet Type (Standard Diets, Irradiated Diets, and Autoclavable Diets), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Discovery & Personalized Medicine, Regenerative Medicine, Pathology of Infectious Diseases, Drug Toxicity & Efficacy Testing, and Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Research & Academic Institutes, and Others)

The laboratory animal diets market in North America is expected to grow from US$ 1,719.20 million in 2022 to US$ 2,304.19 million by 2028; it is estimated to grow at a CAGR of 5.0% from 2022 to 2028.

Rising Use of Mice Models in Virology and Infectious Disease Studies Boost North America Laboratory Animal Diets Market Growth

Mice models are essential tools for studying the pathogenesis of infectious diseases and for the preclinical evaluation of vaccines and therapies against various human pathogens. The use of genetically defined inbred mouse strains, humanized mice, and gene knockout mice has enabled the research community to study pathogens that cause diseases and explain the role of specific host genes in controlling or promoting diseases. It also helps determine potential targets for the prevention or identification of treatments for various infectious agents. With the growing incidences of new infectious diseases, the animal model has become a vital tool for studying disease mechanisms and developing therapeutics. Mice with xenografted human immune systems have been used to study the pathogenesis of various infectious agents, including Plasmodium falciparum (malaria), Mycobacterium tuberculosis , dengue virus, and influenza virus. These models have been beneficial in studying HIV, which includes analyzing viral and host factors that promote viral replication and HIV interactions with the host's immune response. They are also helpful as platforms for testing therapeutic approaches to control HIV infection. Mouse models are widely used for preclinical screening of vaccines/therapies because of their reproducibility, low cost, and ease of experimental manipulation. Over the past century, advancements in vaccines, antibiotics/antivirals, and infection control measures have significantly reduced the burden of infectious diseases across the region. However, there has been an increase in contagious viral diseases. Mouse models are considered the best small animal models to be tested for hepatitis B virus (HBV), hepatitis C virus (HCV), Zika virus, SARS-CoV-2, and cytomegalovirus (CMV). According to the WHO, more than 17 million people die from infectious diseases yearly. Over the past two decades, over 30 new infectious diseases have emerged. According to UNAIDS, 38 million people were affected by HIV by the end of 2019. Mouse models have been widely used for various viral studies due to their small size, low cost, ease of use, and high reproducibility. To study the effect of the vaccines and therapies, these mice models are given a particular standardized diet. The prevalence of viral and infectious diseases is driving the demand for mice models; hence, the requirement for a specific diet for mice models has increased. This is driving the growth of the laboratory animal diet market in North America.

Market Overview

The North America laboratory animal diets market is segmented into the US, Canada, and Mexico. North America accounted for the largest share of the global market in 2021, owing to the increasing demand for laboratory animals by a large number of research institutions and well-established players in the industry across developed countries. Additionally, the rising need for animal models is due to the increased use of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technique. In addition, the development and introduction of personalized medicine products and services mainly emerged in the US market. Concerns regarding the adverse effects of certain drugs and the desire to increase patient participation in medical decisions have the potential to boost the acceptance of personalized medicine in the US. Moreover, the Precision Medicine Initiative was introduced by the government in the US. Under this initiative, the government intends to increase knowledge related to cancer genetics and biology, discover more effective therapeutics for chronic disorders, and promote the use of precision medicine. Rapid developments in regenerative medicine and tissue engineering have witnessed an increasing inclination toward the clinical translation of breakthrough technologies. Various domesticated and companion animals are used in personalized medicine, regenerative medicine, and tissue engineering studies.

North America Laboratory Animal Diets Market Revenue and Forecast to 2028 (US$ Million)

North America Laboratory Animal Diets Market Segmentation

The North America laboratory animal diets market is segmented on the basis of diet type, animal, application, end user, and country.

Based on diet type, the North America laboratory animal diets market is segmented into standard diets, irradiated diets, and autoclavable diets. The standard diets segment is likely to register the largest share of the market in 2022.

Based on animal, the North America laboratory animal diets market is segmented into mouse, cat, dog, rabbit, chicken, and others. The mouse segment is likely to register the largest share of the market in 2022.

Based on application, the North America laboratory animal diets market is segmented into drug discovery and personalized medicines, regenerative medicines, pathology of infectious disease, drug toxicity and efficacy testing, and others. The drug discovery and personalized medicine segment is likely to register the largest share of the market in 2022.

Based on end user, the North America laboratory animal diets market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. The pharmaceutical & biopharmaceutical companies segment is likely to register the largest share of the market in 2022.

Based on country, the North America laboratory animal diets market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.

Altromin Spezialfutter GmbH & Co. KG; Bio-Serv; Dyets, Inc.; Envigo; LabDiet; Research Diets Inc.; SAFE; Special Diet Services; and Specialty Feeds are the leading companies operating in the laboratory animal diets market in North America.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa driving training simulator market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa driving training simulator market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the driving training simulator market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction: 1.1 Scope of the Study; 1.2 The Insight Partners Research Report Guidance; 1.3 Market Segmentation; 1.3.1 North America Laboratory Animal Diet Market – By Diet Type; 1.3.2 North America Laboratory Animal Diet Market – By Animal; 1.3.3 North America Laboratory Animal Diet Market – By Application; 1.3.4 North America Laboratory Animal Diet Market – By End User; 1.3.5 North America Laboratory Animal Diet Market – By Country
2. Key Takeaways
3. Research Methodology: 3.1 Coverage; 3.2 Secondary Research; 3.3 Primary Research
4. North America Laboratory Animal Diet Market – Market Landscape: 4.1 Overview; 4.2 North America PEST Analysis; 4.3 Experts Opinion
5. North America Laboratory Animal Diet Market – Key Market Dynamics: 5.1 Market Drivers; 5.1.1 Growing Consumption of Personalized Medicines; 5.1.2 Rising Usage of Mice Models in Virology and Infectious Disease; 5.2 Market Restraints; 5.2.1 High Cost of Laboratory Animal Diet due to Maintenance and Wastage; 5.3 Market Opportunities; 5.3.1 Rising Demand for Humanized Mice Models; 5.4 Future Trends; 5.4.1 Growing Inclination Toward Customized Diet Plan for Laboratory Animals; 5.5 Impact Analysis
6. Laboratory Animal Diet Market – North America Analysis: 6.1 North America Laboratory Animal Diet Market Revenue Forecast & Analysis
7. North America Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By Diet Type: 7.1 Overview; 7.2 North America Laboratory Animal Diet Market, By Diet Type 2021 & 2028 (%); 7.3 Standard Diet; 7.3.1 Overview; 7.3.2 Standard Diet Market Revenue and Forecast to 2028 (US$ Mn); 7.4 Irradiated Diet; 7.4.1 Overview; 7.4.2 Irradiated Diet Market Revenue and Forecast to 2028 (US$ Mn); 7.5 Autoclavable Diet; 7.5.1 Overview; 7.5.2 Autoclavable Diet Market Revenue and Forecast to 2028 (US$ Mn)
8. North America Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By Animal: 8.1 Overview; 8.2 North America Laboratory Animal Diet Market, By Animal 2021 & 2028 (%); 8.3 Mouse; 8.3.1 Overview; 8.3.2 Mouse Market Revenue and Forecast to 2028 (US$ Mn); 8.4 Cat; 8.4.1 Overview; 8.4.2 Cat Market Revenue and Forecast to 2028 (US$ Mn); 8.5 Dog; 8.5.1 Overview; 8.5.2 Dog Market Revenue and Forecast to 2028 (US$ Mn); 8.6 Rabbit; 8.6.1 Overview; 8.6.2 Rabbit Market Revenue and Forecast to 2028 (US$ Mn); 8.7 Chicken; 8.7.1 Overview; 8.7.2 Chicken Market Revenue and Forecast to 2028 (US$ Mn); 8.8 Others; 8.8.1 Overview; 8.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. North America Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By Application: 9.1 Overview; 9.2 North America Laboratory Animal Diet Market, By Application 2021 & 2028 (%); 9.3 Drug Discovery and Personalized Medicine; 9.3.1 Overview; 9.3.2 Drug Discovery and Personalized Medicine Market Revenue and Forecast to 2028 (US$ Mn); 9.4 Regenerative Medicines; 9.4.1 Overview; 9.4.2 Regenerative Medicines Market Revenue and Forecast to 2028 (US$ Mn); 9.5 Pathology of Infectious Diseases; 9.5.1 Overview; 9.5.2 Pathology of Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn); 9.6 Drug Toxicity and Efficacy Testing; 9.6.1 Overview; 9.6.2 Drug Toxicity and Efficacy Testing Market Revenue and Forecast to 2028 (US$ Mn); 9.7 Others; 9.7.1 Overview; 9.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
10. North America Laboratory Animal Diet Market Analysis and Forecasts To 2028 – By End User: 10.1 Overview; 10.2 North America Laboratory Animal Diet Market, By End User 2021 & 2028 (%); 10.3 Pharmaceutical & Biopharmaceutical Companies; 10.3.1 Overview; 10.3.2 Pharmaceutical & Biopharmaceutical Companies Market Revenue and Forecast to 2028 (US$ Mn); 10.4 Research & Academic Institutes; 10.4.1 Overview; 10.4.2 Research & Academic Institutes Market Revenue and Forecast to 2028 (US$ Mn); 10.5 Others; 10.5.1 Overview; 10.5.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. North America Laboratory Animal Diet Market Revenue and Forecasts to 2028 – Country Analysis: 11.1 Overview; 11.1.1 North America: Laboratory Animal Diet Market, by Country, 2021 & 2028 (%); 11.1.1.1 US: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.1 Overview; 11.1.1.1.2 US: Laboratory Animal Diet Market Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.3 US: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.4 US: Laboratory Animal Diet Market, by Animal– Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.5 US: Laboratory Animal Diet Market, by Application– Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.6 US: Laboratory Animal Diet Market, by End user– Revenue and Forecast to 2028 (US$ Million); 11.1.1.2 Canada: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.1 Overview; 11.1.1.2.2 Canada: Laboratory Animal Diet Market Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.3 Canada: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.4 Canada: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.5 Canada: Laboratory Animal Diet Market, by Application– Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.6 Canada: Laboratory Animal Diet Market, by End user– Revenue and Forecast to 2028 (US$ Million); 11.1.1.3 Mexico: Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.1 Overview; 11.1.1.3.2 Mexico: Laboratory Animal Diet Market Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.3 Mexico: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.4 Mexico: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.5 Mexico: Laboratory Animal Diet Market, by Application– Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.6 Mexico: Laboratory Animal Diet Market, by End user– Revenue and Forecast to 2028 (US$ Million)
12. North America Laboratory Animal Diet Market– Industry Landscape: 12.1 Overview
13. Company Profiles: 13.1 Envigo; 13.1.1 Key Facts; 13.1.2 Business Description; 13.1.3 Products and Services; 13.1.4 Financial Overview; 13.1.5 SWOT Analysis; 13.1.6 Key Developments; 13.2 Altromin Spezialfutter GmbH & Co. KG; 13.2.1 Key Facts; 13.2.2 Business Description; 13.2.3 Products and Services; 13.2.4 Financial Overview; 13.2.5 SWOT Analysis; 13.2.6 Key Developments; 13.3 LabDiet; 13.3.1 Key Facts; 13.3.2 Business Description; 13.3.3 Products and Services; 13.3.4 Financial Overview; 13.3.5 SWOT Analysis; 13.3.6 Key Developments; 13.4 SAFE; 13.4.1 Key Facts; 13.4.2 Business Description; 13.4.3 Products and Services; 13.4.4 Financial Overview; 13.4.5 SWOT Analysis; 13.4.6 Key Developments; 13.5 Dyets, Inc.; 13.5.1 Key Facts; 13.5.2 Business Description; 13.5.3 Products and Services; 13.5.4 Financial Overview; 13.5.5 SWOT Analysis; 13.5.6 Key Developments; 13.6 Special Diet Services; 13.6.1 Key Facts; 13.6.2 Business Description; 13.6.3 Products and Services; 13.6.4 Financial Overview; 13.6.5 SWOT Analysis; 13.6.6 Key Developments; 13.7 Specialty Feeds; 13.7.1 Key Facts; 13.7.2 Business Description; 13.7.3 Products and Services; 13.7.4 Financial Overview; 13.7.5 SWOT Analysis; 13.7.6 Key Developments; 13.8 Research Diets Inc.; 13.8.1 Key Facts; 13.8.2 Business Description; 13.8.3 Products and Services; 13.8.4 Financial Overview; 13.8.5 SWOT Analysis; 13.8.6 Key Developments; 13.9 Bio-Serv; 13.9.1 Key Facts; 13.9.2 Business Description; 13.9.3 Products and Services; 13.9.4 Financial Overview; 13.9.5 SWOT Analysis; 13.9.6 Key Developments
14. Appendix: 14.1 About The Insight Partners; 14.2 Glossary of Terms
LIST OF TABLES: Table 1. North America Laboratory Animal Diet Market – Revenue and Forecast to 2028 (US$ Million); Table 2. US: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million); Table 3. US: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million); Table 4. US: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million); Table 5. US: Laboratory Animal Diet Market, by End user – Revenue and Forecast to 2028 (US$ Million); Table 6. Canada: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million); Table 7. Canada: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million); Table 8. Canada: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million); Table 9. Canada: Laboratory Animal Diet Market, by End user – Revenue and Forecast to 2028 (US$ Million); Table 10. Mexico: Laboratory Animal Diet Market, by Diet Type – Revenue and Forecast to 2028 (US$ Million); Table 11. Mexico: Laboratory Animal Diet Market, by Animal – Revenue and Forecast to 2028 (US$ Million); Table 12. Mexico: Laboratory Animal Diet Market, by Application – Revenue and Forecast to 2028 (US$ Million); Table 13. Mexico: Laboratory Animal Diet Market, by End user – Revenue and Forecast to 2028 (US$ Million); Table 14. Merger and Acquisition Development Done By Company; Table 15. Glossary of Terms
LIST OF FIGURES: Figure 1. North America Laboratory Animal Diet Market Segmentation; Figure 2. North America Laboratory Animal Diet Market, By Country; Figure 3. North America Laboratory Animal Diet Market Overview; Figure 4. North America Laboratory Animal Diet Market, By Diet Type; Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period; Figure 6. North America: PEST Analysis; Figure 7. Experts Opinion; Figure 8. North America Laboratory Animal Diet Market – Revenue Forecast and Analysis – 2020- 2028; Figure 9. North America Laboratory Animal Diet Market, by Diet Type 2021 & 2028 (%); Figure 10. North America Standard Diet Market Revenue and Forecasts to 2028 (US$ Mn); Figure 11. North America Irradiated Diet Market Revenue and Forecasts To 2028 (US$ MN); Figure 12. North America Autoclavable Diet Market Revenue and Forecasts To 2028 (US$ MN); Figure 13. North America Laboratory Animal Diet Market, by Animal 2021 & 2028 (%); Figure 14. North America Mouse Market Revenue and Forecasts to 2028 (US$ Mn); Figure 15. North America Cat Market Revenue and Forecasts to 2028 (US$ Mn); Figure 16. North America Dog Market Revenue and Forecasts to 2028 (US$ Mn); Figure 17. North America Rabbit Market Revenue and Forecasts to 2028 (US$ Mn); Figure 18. North America Chicken Market Revenue and Forecasts to 2028 (US$ Mn); Figure 19. North America Others Market Revenue and Forecasts to 2028 (US$ Mn); Figure 20. North America Laboratory Animal Diet Market, by Application 2021 & 2028 (%); Figure 21. North America Drug Discovery and Personalized Medicine Market Revenue and Forecasts to 2028 (US$ Mn); Figure 22. North America Regenerative Medicines Market Revenue and Forecasts to 2028 (US$ Mn); Figure 23. North America Pathology of Infectious Diseases Market Revenue and Forecasts to 2028 (US$ Mn); Figure 24. North America Drug Toxicity and Efficacy Testing Market Revenue and Forecasts to 2028 (US$ Mn); Figure 25. North America Others Market Revenue and Forecasts to 2028 (US$ Mn); Figure 26. North America Laboratory Animal Diet Market, by End User 2021 & 2028 (%); Figure 27. North America Pharmaceutical & Biopharmaceutical Companies Market Revenue and Forecasts to 2028 (US$ Mn); Figure 28. North America Research & Academic Institutes Market Revenue and Forecasts to 2028 (US$ Mn); Figure 29. North America Others Market Revenue and Forecasts to 2028 (US$ Mn); Figure 30. North America: Laboratory Animal Diet Market Revenue Overview, By Key Country – Revenue (2021) (US$ Million); Figure 31. North America: Laboratory Animal Diet Market, By Country, 2021 & 2028 (%); Figure 32. US: Laboratory Animal Diet Market Revenue and Forecast To 2028 (US$ Million); Figure 33. Canada: Laboratory Animal Diet Market Revenue and Forecast To 2028 (US$ Million); Figure 34. Mexico: Laboratory Animal Diet Market Revenue and Forecast To 2028 (US$ Million)